CD8A and neoplasm: A cluster of dendritic cells, exclusive to the dpNFs, were enriched for immune checkpoint modulators, IDO1 and PD-L1, which also act to impair CD8+ T cells while also inhibiting AMPK signaling, a tumor suppression pathway (54, 163) (Figure 5H, I).